Antiplatelet Agents [phsu]
PREVENT [phsu]
Thrombosis [patf]
Peripheral [spco]
Arterial [bpoc]
Bypass Surgery [topp]
Background [cnce]
peripheral arterial disease [dsyn]
occlusions [patf]
Blockage [fndg]
Main [qlco]
Arteries [bpoc]
Lower Limbs [blor]
One [qnco]
treatment option [topp]
Bypass [topp]
Surgery [bmod]
Using [ftcn]
Autologous [qlco]
Tissue [tisu]
Vein [bpoc]
{Graft} [bodm]
Artificial [qlco]
{Graft} [bodm]
Factor [ftcn]
Occlusion [ortf]
Rate [acty]
Patients [podg]
Including [ftcn]
Material [sbst]
To [qlco]
PREVENT [phsu]
{Graft} [bodm]
Occlusion [ortf]
Patients [podg]
treated [topp]
Drugs [phsu]
Combination [qlco]
objectives [inpr]
To [qlco]
effects [qlco]
Antiplatelet Agents [phsu]
Prevention [topp]
Thrombosis [patf]
People [popg]
Lower Limb [blor]
Atherosclerosis [dsyn]
femoro-popliteal [bpoc]
Femoro-distal bypass [topp]
grafting [tisu]
Outcome [ftcn]
included [ftcn]
Overall [inpr]
Success [socb]
therapy [ftcn]
{Graft} [bodm]
Patency [spco]
Limb Salvage [topp]
Rate [acty]
Complications [patf]
treatment [ftcn]
search [inpr]
Methods [inpr]
Update [tmco]
Peripheral Vascular Diseases [dsyn]
Group [idcn]
Trial [resa]
search [inpr]
Searched [acty]
specialised [qlco]
Last [qlco]
Searched [acty]
Central [spco]
Controlled [ftcn]
Trial [resa]
Issue [fndg]
Additional [ftcn]
Trial [resa]
Screening [hlca]
Reference [idcn]
List [cnce]
Relevant [qlco]
Papers [mnob]
Selection Criteria [qlco]
Two [qnco]
Review [inpr]
Authors [prog]
reviewed [inpr]
studies [lbpr]
Found [qnco]
search [inpr]
Evaluated [ftcn]
Based [ftcn]
Inclusion [qlco]
Exclusion Criteria [ftcn]
resolving [idcn]
Disagreement [socb]
Discussion [topp]
Data Collection [resa]
Analysis [lbpr]
Extracted [topp]
Details [qlco]
Select [acty]
studies [lbpr]
Update [tmco]
Compared [acty]
treatment [ftcn]
Control Groups [grup]
Prognostic Factor [clna]
If [qlco]
Data [idcn]
Unavailable [ftcn]
Further [spco]
Information [idcn]
Study Author [prog]
Data [idcn]
Compare [acty]
Group [idcn]
Result [ftcn]
Address [inpr]
Unit [qnco]
Analysis [lbpr]
Issue [fndg]
subgroup [virs]
Analysis [lbpr]
Main [qlco]
Result [ftcn]
studies [lbpr]
participants [popg]
Nine [qnco]
Different [qlco]
treatment [ftcn]
Group [idcn]
Evaluated [ftcn]
Aspirin [orch, phsu]
ASA [orch, phsu]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
placebo [topp]
Six [qnco]
studies [lbpr]
ASA [orch, phsu]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
Pentoxifylline [orch, phsu]
Two [qnco]
studies [lbpr]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
indobufen [orch, phsu]
One [qnco]
Study [mnob]
ASA [orch, phsu]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
Vitamin K antagonists [phsu]
Two [qnco]
studies [lbpr]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
Heparin, Low-Molecular-Weight [carb, phsu]
One [qnco]
Study [mnob]
Ticlopidine [orch, phsu]
placebo [topp]
One [qnco]
Study [mnob]
ASA [orch, phsu]
One [qnco]
Study [mnob]
ASA [orch, phsu]
Naftidrofuryl [orch, phsu]
One [qnco]
Study [mnob]
clopidogrel [orch, phsu]
ASA [orch, phsu]
ASA [orch, phsu]
Alone [qnco]
One [qnco]
Study [mnob]
treatment [ftcn]
Comparison [acty]
Evaluated [ftcn]
Possible [qlco]
Performed [ftcn]
subgroup [virs]
Analysis [lbpr]
Venous [bpoc]
Grafts [tisu]
Prosthetic graft [bodm]
Different [qlco]
Follow-up [fndg]
Time Point [tmco]
Quality [qlco]
Evidence [ftcn]
low [qlco]
Moderate [qlco]
treatment [ftcn]
Comparison [acty]
Very [qlco]
Study [mnob]
To [qlco]
Contribute [acty]
Data [idcn]
Several [qnco]
included [ftcn]
studies [lbpr]
Unit [qnco]
Analysis [lbpr]
Issue [fndg]
treatment [ftcn]
Dosages [qnco]
studies [lbpr]
Data [idcn]
Outcome [ftcn]
Review [inpr]
Not [ftcn]
GIVEN [cnce]
studies [lbpr]
studies [lbpr]
Overall [inpr]
Study [mnob]
Quality [qlco]
Moderate [qlco]
Largest [qnco]
Problem [fndg]
majority [socb]
studies [lbpr]
Not [ftcn]
Methods [inpr]
Randomization [resa]
Allocation [acty]
Blinding [resa]
Outcome [ftcn]
Assessor [prog]
Leading [tmco]
To [qlco]
Risk [qlco]
Rating [acty]
Main [qlco]
Issue [fndg]
Study [mnob]
Quality [qlco]
Study [mnob]
Not [ftcn]
Blinding [resa]
participants [popg]
personnel [ftcn]
treatment [ftcn]
Comparison [acty]
Most [qnco]
included [ftcn]
studies [lbpr]
allowed [socb]
Robust [qlco]
Conclusions [idcn]
Aspirin [orch, phsu]
ASA [orch, phsu]
ASA [orch, phsu]
Dipyridamole [orch, phsu]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
placebo [topp]
Covered [ftcn]
Six [qnco]
studies [lbpr]
treatment [ftcn]
Group [idcn]
Improved [qlco]
{Graft} [bodm]
Patency [spco]
ASA [orch, phsu]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
treatment [ftcn]
Group [idcn]
Odds Ratio [qnco]
Confidence Interval [qnco]
P NOS [aapp, imft]
participants [popg]
This [euka]
Effect [qlco]
Not [ftcn]
Seen [qlco]
Venous [bpoc]
Grafts [tisu]
Alone [qnco]
Time Point [tmco]
Observed [ftcn]
Time Point [tmco]
Prosthetic graft [bodm]
Including [ftcn]
Final [tmco]
Time Point [tmco]
months [tmco]
Odds Ratio [qnco]
Confidence Interval [qnco]
P NOS [aapp, imft]
participants [popg]
Only [qnco]
Single [popg]
Study [mnob]
Evaluated [ftcn]
secondary [neop]
Patency [spco]
treatment [ftcn]
Group [idcn]
Comparison [acty]
ASA [orch, phsu]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
placebo [topp]
side effects [ftcn]
Including [ftcn]
General [spco]
gastrointestinal [spco]
Bleeding [patf]
Wound Infection [patf]
{Graft} [bodm]
Amputations [topp]
cardiovascular events [fndg]
Mortality [qnco]
Similar [qlco]
treatment [ftcn]
Group [idcn]
Comparison [acty]
ASA [orch, phsu]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
Vitamin K antagonists [phsu]
included [ftcn]
Two [qnco]
studies [lbpr]
One [qnco]
Very large [fndg]
Over [spco]
participants [popg]
treatment [ftcn]
Primary [qlco]
{Graft} [bodm]
Patency [spco]
Three [qnco]
Six [qnco]
months [tmco]
Evidence [ftcn]
Limb amputation [topp]
cardiovascular events [fndg]
Mortality [qnco]
One [qnco]
Large [qnco]
Study [mnob]
participants [popg]
Evaluated [ftcn]
clopidogrel [orch, phsu]
ASA [orch, phsu]
ASA [orch, phsu]
Alone [qnco]
{Graft} [bodm]
Evidence [ftcn]
Primary [qlco]
Patency [spco]
months [tmco]
Evidence [ftcn]
Increased [qnco]
Bleeding [patf]
clopidogrel [orch, phsu]
ASA [orch, phsu]
Group [idcn]
Odds Ratio [qnco]
Confidence Interval [qnco]
Increase [ftcn]
Mild [qlco]
Odds Ratio [qnco]
Confidence Interval [qnco]
Moderate [qlco]
Bleeding [patf]
Odds Ratio [qnco]
Confidence Interval [qnco]
Severe [qlco]
Fatal [qlco]
Bleeding [patf]
treatment [ftcn]
Group [idcn]
Limb amputation [topp]
Mortality [qnco]
Remaining [qlco]
treatment [ftcn]
Comparison [acty]
Not [ftcn]
Currently [tmco]
Evidence [ftcn]
Draw [inpr]
Robust [qlco]
Conclusions [idcn]
Efficacy [qlco]
Safety [hcpp]
treatment [ftcn]
{Graft} [bodm]
Patency [spco]
Peripheral [spco]
Bypass [topp]
Authors [prog]
Conclusions [idcn]
antiplatelet therapy [topp]
Aspirin [orch, phsu]
ASPIRIN/DIPYRIDAMOLE [orch, phsu]
Plus [qlco]
Effect [qlco]
Primary [qlco]
Patency [spco]
Peripheral [spco]
bypass grafts [topp]
Compared [acty]
placebo [topp]
treatment [ftcn]
This [euka]
Effect [qlco]
Not [ftcn]
Evidence [ftcn]
Evaluate [ftcn]
Venous [bpoc]
Grafts [tisu]
Alone [qnco]
antiplatelet therapy [topp]
Effect [qlco]
Patency [spco]
Prosthetic graft [bodm]
Evidence [ftcn]
side effects [ftcn]
Including [ftcn]
General [spco]
gastrointestinal [spco]
Bleeding [patf]
Infection, NOS [dsyn]
Amputation [topp]
cardiovascular events [fndg]
Mortality [qnco]
treatment [ftcn]
Group [idcn]
participants [popg]
included [ftcn]
Analysis [lbpr]
Small [qnco]
detect [fndg]
statistically significant [qnco]
Effect [qlco]
side effects [ftcn]
Amputation [topp]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
Found [qnco]
Primary [qlco]
{Graft} [bodm]
Patency [spco]
Aspirin [orch, phsu]
Aspirin [orch, phsu]
Dipyridamole [orch, phsu]
Compared [acty]
vitamin k antagonist [topp]
clopidogrel [orch, phsu]
Aspirin [orch, phsu]
Compared [acty]
Aspirin [orch, phsu]
Alone [qnco]
Evidence [ftcn]
Increase [ftcn]
Bleeding [patf]
clopidogrel [orch, phsu]
Aspirin [orch, phsu]
Group [idcn]
Comparison [acty]
Remaining [qlco]
Six [qnco]
treatment [ftcn]
Comparison [acty]
Not [ftcn]
Data [idcn]
Draw [inpr]
Robust [qlco]
Conclusions [idcn]
Efficacy [qlco]
Safety [hcpp]
Time [tmco]
